Jefferies Group's DXCM Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 37,629 shares of DexCom, Inc. (DXCM) worth $2.5 M, representing 0.01% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in DXCM, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 34,065 shares. Largest reduction occurred in Q4 2023, reducing 53,580 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's DexCom (DXCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly DexCom (DXCM) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +20,417 | Add 118.62% | 37,629 | $66.37 |
| Q3 2025 | +10,075 | Add 141.17% | 17,212 | $67.29 |
| Q2 2025 | -13,725 | Reduce 65.79% | 7,137 | $87.29 |
| Q1 2025 | -12,781 | Reduce 37.99% | 20,862 | $68.29 |
| Q4 2024 | +10,979 | Add 48.44% | 33,643 | $77.77 |
| Q3 2024 | +16,598 | Add 273.62% | 22,664 | $67.04 |
| Q2 2024 | -321 | Reduce 5.03% | 6,066 | $113.38 |
| Q1 2024 | -369 | Reduce 5.46% | 6,387 | $138.70 |
| Q4 2023 | -53,580 | Reduce 88.80% | 6,756 | $124.09 |
| Q3 2023 | +34,065 | Add 129.67% | 60,336 | $93.30 |
| Q2 2023 | -14,149 | Reduce 35.00% | 26,271 | $128.51 |
| Q1 2023 | -29,962 | Reduce 42.57% | 40,420 | $116.18 |
| Q4 2022 | +70,382 | New Buy | 70,382 | $113.24 |
Jefferies Group's DexCom Investment FAQs
Jefferies Group first purchased DexCom, Inc. (DXCM) in Q4 2022, acquiring 70,382 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held DexCom, Inc. (DXCM) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to DexCom, Inc. (DXCM) was in Q4 2022, adding 70,382 shares worth $7.97 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 37,629 shares of DexCom, Inc. (DXCM), valued at approximately $2.5 M.
As of the Q4 2025 filing, DexCom, Inc. (DXCM) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in DexCom, Inc. (DXCM) was 70,382 shares, as reported at the end of Q4 2022.